241 related articles for article (PubMed ID: 27330109)
21. Cytokine expression by invariant natural killer T cells is tightly regulated throughout development and settings of type-2 inflammation.
O'Brien TF; Bao K; Dell'Aringa M; Ang WX; Abraham S; Reinhardt RL
Mucosal Immunol; 2016 May; 9(3):597-609. PubMed ID: 26349658
[TBL] [Abstract][Full Text] [Related]
22. Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells.
Wang X; Lei L; Su Y; Liu J; Yuan N; Gao Y; Yang X; Sun C; Ning B; Zhang B
J Cell Mol Med; 2022 Aug; 26(15):4268-4276. PubMed ID: 35770325
[TBL] [Abstract][Full Text] [Related]
23. Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice.
Lau I; de Amat Herbozo C; Kuypers M; Lin Q; Paget C; Mallevaey T
Immunohorizons; 2020 Dec; 4(12):797-808. PubMed ID: 33323387
[TBL] [Abstract][Full Text] [Related]
24. mTOR and its tight regulation for iNKT cell development and effector function.
Yang W; Gorentla B; Zhong XP; Shin J
Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
[TBL] [Abstract][Full Text] [Related]
25. Unraveling Natural Killer T-Cells Development.
Bennstein SB
Front Immunol; 2017; 8():1950. PubMed ID: 29375573
[TBL] [Abstract][Full Text] [Related]
26. The Protein Phosphatase Shp1 Regulates Invariant NKT Cell Effector Differentiation Independently of TCR and Slam Signaling.
Cruz Tleugabulova M; Zhao M; Lau I; Kuypers M; Wirianto C; Umaña JM; Lin Q; Kronenberg M; Mallevaey T
J Immunol; 2019 Apr; 202(8):2276-2286. PubMed ID: 30796181
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-155 Controls
Wang J; Li K; Zhang X; Li G; Liu T; Wu X; Brown SL; Zhou L; Mi QS
Front Cell Dev Biol; 2020; 8():619220. PubMed ID: 33585457
[TBL] [Abstract][Full Text] [Related]
28. Invariant NKT cell development: focus on NOD mice.
Ghazarian L; Simoni Y; Magalhaes I; Lehuen A
Curr Opin Immunol; 2014 Apr; 27():83-8. PubMed ID: 24637104
[TBL] [Abstract][Full Text] [Related]
29. Activation of hepatic iNKT2 cells by α-GalCer ameliorates hepatic steatosis induced by high-fat diet in C57BL/6J mice.
Chen D; Gao X; Wang J; Zhao H; Liu H; Chen S; Zhang J; Meng M
Int Immunopharmacol; 2019 Sep; 74():105727. PubMed ID: 31284229
[TBL] [Abstract][Full Text] [Related]
30. PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision.
Wang K; Zhang X; Wang Y; Jin G; Li M; Zhang S; Hao J; Jin R; Huang X; Wu H; Zhang J; Chen Y; Ge Q
Cell Mol Immunol; 2019 Sep; 16(9):746-756. PubMed ID: 29921968
[TBL] [Abstract][Full Text] [Related]
31. Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8
Helm EY; Zelenka T; Cismasiu VB; Islam S; Silvane L; Zitti B; Holmes TD; Drashansky TT; Kwiatkowski AJ; Tao C; Dean J; Obermayer AN; Chen X; Keselowsky BG; Zhang W; Huo Z; Zhou L; Sheridan BS; Conejo-Garcia JR; Shaw TI; Bryceson YT; Avram D
Sci Immunol; 2023 Apr; 8(82):eabn0484. PubMed ID: 37115913
[TBL] [Abstract][Full Text] [Related]
32. Proliferation and Directional Differentiation of iNKT Cells Derived from DBA/1 Mice Thymus.
Chen D; Li Z; Liang R; Liu H; Wang Y; Shi H; Meng M
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):623-634. PubMed ID: 34664821
[TBL] [Abstract][Full Text] [Related]
33. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
[TBL] [Abstract][Full Text] [Related]
34. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
[TBL] [Abstract][Full Text] [Related]
35. The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic
Won HY; Kim HK; Crossman A; Awasthi P; Gress RE; Park JH
Front Immunol; 2021; 12():642856. PubMed ID: 34054809
[TBL] [Abstract][Full Text] [Related]
36. Deconstructing iNKT cell development at single-cell resolution.
Baranek T; de Amat Herbozo C; Mallevaey T; Paget C
Trends Immunol; 2022 Jul; 43(7):503-512. PubMed ID: 35654639
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of IL-17-Producing Invariant Natural Killer T Cells Requires Expression of the Transcription Factor c-Maf.
Yu JS; Hamada M; Ohtsuka S; Yoh K; Takahashi S; Miaw SC
Front Immunol; 2017; 8():1399. PubMed ID: 29163480
[TBL] [Abstract][Full Text] [Related]
38. NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes.
Simoni Y; Gautron AS; Beaudoin L; Bui LC; Michel ML; Coumoul X; Eberl G; Leite-de-Moraes M; Lehuen A
Eur J Immunol; 2011 Dec; 41(12):3574-85. PubMed ID: 22002883
[TBL] [Abstract][Full Text] [Related]
39. Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology.
Tumes D; Hirahara K; Papadopoulos M; Shinoda K; Onodera A; Kumagai J; Yip KH; Pant H; Kokubo K; Kiuchi M; Aoki A; Obata-Ninomiya K; Tokoyoda K; Endo Y; Kimura MY; Nakayama T
J Allergy Clin Immunol; 2019 Aug; 144(2):549-560.e10. PubMed ID: 30851295
[TBL] [Abstract][Full Text] [Related]
40. Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions.
Raynor JL; Liu C; Dhungana Y; Guy C; Chapman NM; Shi H; Neale G; Sesaki H; Chi H
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32289155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
